Sociedad Americana de Hirudoterapia

Aeromonas characteristics in Iran, Southwest Asia; a systematic review and meta-analysis on epidemiology, reservoirs and antibiotic resistance profile from aquatic environments to human society during 2000-2023

Research article published in BMC veterinary research (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Meta-analysisResistencia antimicrobianaMoradi et al. · BMC veterinary research, 2025

Abstract

BACKGROUND: As recent evidence shows the prevalence and transmission of Aeromonas species in Southwest Asia, and there is no updated information on the characteristics of Aeromonas in Iran, we conducted this review. We systematically searched biomedical databases (PubMed, Web of Sciences, Scopus, SID, ISC, and Google Scholar) to identify relevant studies investigating the prevalence, antibiotic resistance, and main reservoirs of Aeromonas in aquatic animals and human clinical specimens during 2000-2023 in Iran. Cochrane's Q test and I^2 statistical test was used to assess heterogeneity, and publication bias was assessed using funnel plots and random effects tests. RESULTS: In Iran, among 8347 human clinical samples and 1802 animal and food samples, only 87 (1.04%) and 388 (21.53%) samples were positive for Aeromonas spp. respectively, and the most isolated species was A. hydrophila. The main reservoir for Aeromonas spp. were twenty-four genera of aquatic animals besides minced meat, pigeon stool and chicken meat. In Iran, Aeromonas spp. isolates showed maximum resistance to ampicillin, tetracycline, nalidixic acid and vancomycin. The heterogeneity test for prevalence of Aeromonas species on human samples and animals or food products was significant (88.1256, (5), P-value < 0.0001) and the heterogeneity rate was 97.34% with a confidence interval of 0.2-4.3 and (194.02, (10), P-value < 0.0001) and the heterogeneity rate was 94.85% with a confidence interval of 15,124 - 33,335 respectively. CONCLUSIONS: According to these results, it is essential for exclusive attention to the prevalence and antibiotic resistance of Aeromonas in different provinces of Iran. Furthermore, special planning should be done for prevention, outbreak control and proper treatment of infections in the aquaculture industry and human societies.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleSystematic ReviewMeta-Analysis
Indexed MeSH termsAnimalsHumansAeromonasAnti-Bacterial AgentsDisease ReservoirsDrug Resistance, BacterialGram-Negative Bacterial InfectionsIranPrevalence

Resumen

Peer-reviewed research on antimicrobial resistance relevant to Aeromonas and leech-associated infection. Indexed in PubMed and verified against the NCBI record.

Por qué esto importa para la hirudoterapia

Esta revisión sistemática y metaanálisis de datos iraníes (2000-2023) agrupó 8,347 muestras clínicas humanas y 1,802 muestras de animales/alimentos, hallando una positividad para Aeromonas del 1.04% en muestras humanas y del 21.53% en muestras de animales/alimentos (más comúnmente A. hydrophila), con una resistencia máxima a ampicilina, tetraciclina, ácido nalidíxico y vancomicina. La conexión con la hirudoterapia es relevante porque Aeromonas (destacando A. hydrophila) es el simbionte intestinal implicado en las infecciones de heridas posteriores a la terapia con sanguijuelas, por lo que los patrones regionales de resistencia a los antibióticos orientan las decisiones de profilaxis y la advertencia de larga data de que la cobertura con la clase de fluoroquinolonas es típica. Advertencias: este metaanálisis se centra en la epidemiología de Aeromonas del entorno acuático y clínico general en un solo país, no en las infecciones por terapia con sanguijuelas específicamente; los autores reportan una alta heterogeneidad estadística (I^2 ~95-97%); y los perfiles de resistencia son específicos geográfica y temporalmente, por lo que no pueden generalizarse a la profilaxis para la terapia con sanguijuelas en otros lugares sin datos locales.

Citación

Aeromonas characteristics in Iran, Southwest Asia; a systematic review and meta-analysis on epidemiology, reservoirs and antibiotic resistance profile from aquatic environments to human society during 2000-2023.

Moradi et al. · BMC veterinary research, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.